R-Zero

• 20/02/2023
• Series C
• $150,000,000

R-Zero is the first biosafety technology company dedicated to making the indoor spaces we share safer, healthier and more productive.

We develop the most effective and innovative biosafety technologies, enabling a higher standard of health and safety in the built environment. We are pioneering the first continuous, automated disinfection ecosystem, enabling every organization to measure and manage indoor health with a new level of sophistication and ease. Today, our sustainable, IoT-enabled disinfection technologies are enabling safety for hundreds of thousands of people across the country. Founded in April 2020, R-Zero is backed by the Mayo Clinic, as well as leading venture capital firms and thought leaders across health, hospitality, sports, commercial real estate, and impact sectors.

Together, we are ushering in a new era of health and safety, via accessible technology. Come join our mission to create a better future. rzero.com/careers/

---

---